AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine
Notified -
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2026-01-15, 05:02
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2026-01-07, 22:20
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2025-12-30, 20:00
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2025-12-18, 23:48
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2025-12-11, 00:30
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2025-12-05, 00:30
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2025-12-01, 19:43
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2025-11-10, 19:46
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2025-11-04, 16:30
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2025-11-04, 01:50
